Mrs. Randi Jo Peyrot Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5823 Resource Dr, Harrison, AR 72601 Phone: 870-429-9100 |
Ms. Mary L Killian, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2150 Highway 65 S, Harrison, AR 72601 Phone: 870-421-8945 |
Sydney Griswold, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 702 N Main St, Harrison, AR 72601 Phone: 870-688-6140 |
Kevin Stockton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4408 Turnbury Ln., Harrison, AR 72601 Phone: 870-416-9940 |
Mrs. Amanda L. Saul, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5823 Resource Drive, Harrison, AR 72601 Phone: 870-429-9100 Fax: 870-429-9099 |
Amy Hudson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 W Central Ave, Harrison, AR 72601 Phone: 870-741-7735 |
Brittanie Nichole Miller, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 702 N Main St Ste C, Harrison, AR 72601 Phone: 870-204-5330 |
Ms. Janette Brown, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 245 Southgate Dr, Harrison, AR 72601 Phone: 870-743-4892 |
Julie Foster, Speech Language Pathologist, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1898 Foley Rd, Harrison, AR 72601 Phone: 479-970-1302 |
Ms. Rita Ray Hunter, MCD,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 S Cherry St, Harrison, AR 72601 Phone: 870-741-7600 |
Mrs. Frances R Rayburn, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 E Rush Ave, Harrison, AR 72601 Phone: 479-414-9733 |
Toshia R Whiteside Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3311 Mountain Vista Rd, Harrison, AR 72601 Phone: 870-577-0584 |
Reagan C Leslie, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 525 Old Bellefonte Rd, Harrison, AR 72601 Phone: 870-743-9100 Fax: 870-743-9099 |
Nataley R Merz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 916 Goblin Dr, Harrison, AR 72601 Phone: 870-204-5330 |
Emily Sue Leigvold Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Roberta St, Harrison, AR 72601 Phone: 608-495-0816 |
Natasha Clark Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Maplewood Rd, Harrison, AR 72601 Phone: 870-741-5001 |
Aileen Torres Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1120 W Holt Ave, Harrison, AR 72601 Phone: 870-741-5821 |
Jennifer Lewis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 S Cherry St, Harrison, AR 72601 Phone: 870-741-7600 |
Mrs. Tamara Carrell Griggs, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 383 Gardenia Ln, Harrison, AR 72601 Phone: 870-577-5234 |
Tara B Mckinney, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 497 Creamer Ln, Harrison, AR 72601 Phone: 870-391-3782 |
News Archive
Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
"Two years after some $22 million in donor funds were pumped into malaria control along the Cambodia-Thailand border to fight off suspected resistance to treatment, health workers say the battle is not over," IRIN reports, adding, "The government reported 103,000 malaria infections and 151 deaths nationwide in 2010.
LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 9 days ago